首页 > 市场调查报告书 > 医疗设备

e保健医院 IT

市场调查报告书

商品编码

1516405

电子处方市场 - 按产品（解决方案{整合、独立}、服务）、交付模式（基于网路/云端、本地）、物质（受控、非受控）、使用（手持式、基于电脑）、专业、最终用途，全球预测（2024 - 2032）

ePrescribing Market - By Product (Solutions {Integrated, Standalone}, Services), Delivery Mode (Web/Cloud-based, On-premises), Substances (Controlled, Non-controlled), Usage (Handheld, Computer-based), Specialties, End-use, Global Forecast (2024 - 2032)

出版日期: 2024年04月11日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在大型企业合作伙伴关係和联盟兴起的推动下，全球电子处方市场从 2024 年到 2032 年的复合年增长率将达到 23.9%。这种合作对于电子处方系统在全球的采用至关重要。随着医疗保健提供者和组织寻求增强患者安全、提高用药依从性并简化医疗保健流程，电子处方解决方案提供了显着的优势。

例如，2023 年10 月，提供准确医疗决策的领先医疗技术提供者FDB 和以其医疗资讯和技术解决方案而闻名的Veradigm 宣布建立合作伙伴关係，推出第一个Veradigm 和电子健康记录(EHR) 网络，以连接FDB Vela(TM) 电子处方网路。 Veradigm FDB 将把 Vela ePrescribeng 网路与一系列为使用者和合作伙伴提供的解决方案整合起来。

科技公司、製药公司和医疗保健提供者之间的合作促进了电子处方与电子健康记录 (EHR) 系统和远距医疗平台的整合。这种整合改善了协作和资料交换，并确保医疗保健中准确有效地开立药物。此外，跨平台协议推动了电子处方软体的创新，重点关注用户友好的介面、先进的决策支援工具和监管标准。

整个电子处方产业根据产品、交付模式、物质、用途、专业、最终用户和地区进行分类。

从 2024 年到 2032 年，服务领域的电子处方市场收入将实现令人称讚的复合年增长率。医疗保健提供者和组织正在采用电子处方解决方案来提高生产力、与电子健康记录 (EHR) 整合并满足监管标准。

此外，电子处方服务还提供即时药物交互作用警报、药物分析和电子处方等先进功能，可提高用药依从性和患者护理，例如全球医疗保健。随着数位转型的持续进行，对综合电子调度服务的需求持续成长。提供者将利用这些服务来提高营运效率，减少与药物相关的错误，并最终改善患者护理。

从 2024 年到 2032 年，本地市场将显着成长。

将这些系统与电子健康记录 (EHR) 和现有实践管理软体无缝整合的卫生系统提供了可根据需要自订的资源。透过提供现场电子处方，医疗保健组织保留了完整的资料管理和存取控制，这对于确保患者隐私和遵守行业特定法规至关重要。儘管医疗保健提供者优先考虑资料安全和绩效管理，但现场电子处方解决方案需要支援有效的处方管理和整体病患照护。

2024年至2032年，欧洲电子处方市场将呈现显着的复合年增长率。欧洲国家越来越多地采用电子健康记录 (EHR) 并整合电子处方功能，以促进医疗保健系统中的药物管理。

此外，欧盟委员会的电子医疗行动计划和数位单一市场策略等监管倡议正在鼓励采用电子处方，以实现标准化的健康实践并改善患者的治疗结果。欧洲的卫生专业人员正在投资先进的电子处方系统，该系统提供决策支援工具、取得用药历史和电子处方等功能。随着医疗保健服务的发展，欧洲对全面、互动式电子处方解决方案的需求不断扩大，以支持以病人为中心的全面照护途径。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 12 章：公司简介

Allscripts Healthcare, LLC
Athenahealth
Change Healthcare
DrFirst
Epic Systems Corporation
McKesson Corporation
Networking Technology, Inc.
NXGN Management, LLC
Practice Fusion, Inc.
Surescripts

简介目录

Product Code: 8999

Global ePrescribing Market will observe a CAGR of 23.9% from 2024 to 2032, driven by the rise of large-scale corporate partnerships and alliances. This collaboration is crucial in the worldwide adoption of electronic prescribing systems. As healthcare providers and organizations seek to enhance patient safety, improve medication adherence, and streamline healthcare, e-prescribing solutions offer significant benefits.

For instance, in October 2023, FDB, a leading medical technology provider of accurate healthcare decisions, and Veradigm, known for its healthcare information and technology solutions, announced a partnership to launch the first Veradigm and Electronic Health Record (EHR) network to connect to the FDB Vela(TM) ePrescribing Network. Veradigm FDB will integrate the Vela ePrescribeng network with a range of solutions for users and partners.

Partnerships between technology companies, pharmaceutical companies, and healthcare providers facilitate the integration of e-prescribing with electronic health record (EHR) systems and telemedicine platforms. This integration improves collaboration and data exchange and ensures medication is prescribed accurately and effectively in health care. Additionally, a cross-platform agreement drives innovation in ePrescribing software, focusing on user-friendly interfaces, advanced decision support tools, and regulatory standards.

The overall ePrescribing industry is classified based on product, delivery mode, substances, usage, specialties, end-user, and region.

The ePrescribing market revenue from the services segment will register a commendable CAGR from 2024 to 2032. The functionality of e-prescribing is essential to streamline medication management, reduce prescribing errors, and improve overall health outcomes. Healthcare providers and organizations are adopting e-prescribing solutions to increase productivity, integrate with electronic health records (EHRs), and meet regulatory standards.

In addition, e-prescribing services offer advanced features such as real-time drug interaction alerts, drug analytics, and electronic prescriptions, which improve medication adherence and patient care, such as healthcare worldwide. As the transition to digital transformation continues, the demand for comprehensive e-scheduling services continues to grow. Providers will use these services to achieve operational efficiencies, reduce medication-related errors, and ultimately improve patient care.

The on-premises segment will witness an appreciable growth from 2024 to 2032. Campus e-prescribing systems allow healthcare providers to manage patient prescriptions in their systems, ensuring confidentiality and adherence to regulatory guidelines.

Health systems that seamlessly integrate these systems with electronic health records (EHRs) and existing practice management software provide resources that can be customized as needed. By providing on-site e-prescribing, healthcare organizations retain full data management and access control, which is critical to ensure patient privacy and compliance with industry-specific regulations. Whereas healthcare providers prioritize data security and performance management, on-site e-prescribing solutions are required to support effective prescription management and overall patient care.

Europe ePrescribing market will exhibit a notable CAGR from 2024 to 2032. E-prescribing plays an important role in improving medication safety, reducing prescribing errors, and increasing access to health care. European countries are increasingly adopting electronic health records (EHRs) and integrating ePrescribing functions to facilitate medication management in healthcare systems.

In addition, regulatory initiatives such as the European Commission's eHealth Action Plan and the Digital Single Market Strategy are encouraging the adoption of e-prescribing to achieve standardized health practices and improve patient outcomes. Health professionals in Europe are investing in advanced ePrescribing systems that provide features such as decision support tools, access to medication history, and electronic prescribing. As healthcare delivery evolves, the demand for comprehensive and interactive e-prescribing solutions continues to expand in Europe to support integrated and patient-centered care pathways.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing adoption of electronic health records (EHR)
  - 3.2.1.2 Favorable government policies and funding
  - 3.2.1.3 Increasing expenditure on healthcare
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Concern regarding security
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Million)

5.1 Key trends
5.2 Solutions
- 5.2.1 Integrated solutions
- 5.2.2 Standalone solutions
5.3 Services
- 5.3.1 Support
- 5.3.2 Implementation
- 5.3.3 Training
- 5.3.4 Network

Chapter 6 Market Estimates and Forecast, By Delivery Mode, 2021 - 2032 ($ Million)

6.1 Key trends
6.2 Web/cloud-based
6.3 On-premises

Chapter 7 Market Estimates and Forecast, By Substances, 2021 - 2032 ($ Million)

7.1 Key trends
7.2 Controlled substances
7.3 Non-controlled substances

Chapter 8 Market Estimates and Forecast, By Usage, 2021 - 2032 ($ Million)

8.1 Key trends
8.2 Handheld
8.3 Computer-based devices

Chapter 9 OMarket Estimates and Forecast, By Specialties, 2021 - 2032 ($ Million)

9.1 Key trends
9.2 Oncology
9.3 Sports medicine
9.4 Neurology
9.5 Cardiology
9.6 Other specialties

Chapter 10 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Million)

10.1 Key trends
10.2 Hospital
10.3 Office-based physicians
10.4 Pharmacy
10.5 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

11.1 Key trends
11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Spain
- 11.3.5 Italy
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 Rest of Asia Pacific
11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Rest of Middle East and Africa